Novartis Investigative Site

Suwon 442-723

0 studies enrolling now · 4 studies all time

What they study most

Acute Heart Failure, Diabetes Mellitus, Type 2, Neoplasms, Gastrointestinal Tract, Non-Small Cell Lung Cancer

Studies at this site

• LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib — Completed
• ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer — Stopped early
• Global Non-interventional Heart Failure Disease Registry — Stopped early
• Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic Patients — Stopped early